These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22569382)

  • 41. Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy.
    Leung AK; Weisbrod DJ; Schwartz C
    Can J Ophthalmol; 2010 Jun; 45(3):300-1. PubMed ID: 20379284
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series.
    Parodi MB; Iacono P; Papayannis A; Kontadakis SD; Cascavilla M; Pierro L; Gagliardi M; Bandello F
    Am J Ophthalmol; 2013 Jan; 155(1):103-108.e2. PubMed ID: 23022164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
    Narayanan R; Shah VA
    Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
    Konstantinidis L; Mantel I; Zografos L; Ambresin A
    Eur J Ophthalmol; 2010; 20(5):955-8. PubMed ID: 20306440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microvasculature Changes of Myopic Choroidal Neovascularization and the Predictive Value of Feeder Vessel Disappearance after Ranibizumab Treatment Revealed Using Optical Coherence Tomography Angiography.
    Giorno P; Iacono P; Scarinci F; Di Renzo A; Varano M; Parravano M
    Ophthalmologica; 2020; 243(4):263-270. PubMed ID: 31838464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.
    Roy R; Saurabh K; Das D; Panigrahi PK; Das S; Pal SS; Jain A
    Semin Ophthalmol; 2017; 32(6):781-786. PubMed ID: 27533737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation.
    Papastefanou VP; Nogueira V; Hay G; Andrews RM; Harris M; Cohen VM; Sagoo MS
    Br J Ophthalmol; 2013 Aug; 97(8):1014-9. PubMed ID: 23686326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
    Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
    Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration.
    Parodi MB; Iacono P; La Spina C; Iuliano L; Lo Giudice G; Introini U; Bandello F
    Retina; 2014 Nov; 34(11):2167-70. PubMed ID: 24999724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab.
    Almony A; Mansouri A; Shah GK; Blinder KJ
    Can J Ophthalmol; 2011 Apr; 46(2):182-5. PubMed ID: 21708088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of myopic maculopathy after treatment of choroidal neovascularization.
    Farinha CL; Baltar AS; Nunes SG; Figueira JP; Pires IA; Cachulo ML; Silva RM
    Ophthalmologica; 2014; 231(4):211-20. PubMed ID: 24662778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
    Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
    Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early neovascular bridging of choroidal neovascularization after ranibizumab treatment.
    Reche-Frutos J; Calvo-Gonzalez C; Donate-Lopez J; Garcia-Feijoo J
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1427-30. PubMed ID: 19621235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization.
    Oishi A; Yamashiro K; Tsujikawa A; Ooto S; Tamura H; Nakata I; Miyake M; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):1-7. PubMed ID: 22527326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt's disease.
    Querques G; Bocco MC; Soubrane G; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):319-21. PubMed ID: 17934751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multifocal electroretinography and optical coherence tomography changes after repeated intravitreal bevacizumab (Avastin) in myopic choroidal neovascularization.
    Sabry D; Gad MA; Enam KM
    Retina; 2013 Mar; 33(3):598-605. PubMed ID: 23064427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta.
    Rishi P; Rishi E; Venkatraman A
    Indian J Ophthalmol; 2012; 60(3):229-31. PubMed ID: 22569391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.
    Mimoun G; Tilleul J; Leys A; Coscas G; Soubrane G; Souied EH
    Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.